Leslie Randall
MD
Director, Gyn Oncology Research
Inova Schar Cancer Institute

Dr. Leslie Randall is the Director of Gynecologic Oncology Cancer Clinical Trials at the Inova Schar Cancer Institute and the Division Chief of Gynecologic Oncology Women's Service Line at Inova Health System, Fairfax VA. Dr. Randall earned her medical degree at the University of Louisville School of Medicine and her Master of Science degree in Advanced Clinical Research at the University of California, San Diego. She completed her Obstetrics and Gynecology residency at the University of Louisville School of Medicine and her Gynecologic Oncology fellowship at the University of California, Irvine. Dr. Randall is board-certified by the American Board of Obstetrics and Gynecology with a subspecialty in Gynecologic Oncology. An active member of the International Gynecologic Cancer Society, Society of Gynecologic Oncology, the American Society of Clinical Oncology, and a Fellow of the American College of Surgeons. Dr. Randall is a passionate clinical investigator, she is the current Cervical Cancer Clinical Trials Lead for GOG Partners in the GOG Foundation, and she serves on the Ovarian Cancer and Developmental Therapeutics Committees for NRG Oncology. Dr. Randall conducts patient-oriented research for all gynecologic malignancies with a focus on ovarian, cervical, and endometrial cancers. She has an extensive research background with experience in the design, conduct, analysis, and reporting of early- to late-phase trials, including both therapeutics and surgery.

Sessions

Register
General Session

Debate: What is the Most Impactful Time to Use Immune Checkpoint Inhibitors: Locally Advanced Cervical Cancer or in Combination with Chemotherapy in the First-Line Metastatic Setting? - Locally Advanced Cervical Cancer

Friday, November 01, 2024
1:35 PM - 1:50 PM
General Session

Debate: What is the Most Impactful Time to Use Immune Checkpoint Inhibitors: Locally Advanced Cervical Cancer or in Combination with Chemotherapy in the First-Line Metastatic Setting? - DISCUSSION

Friday, November 01, 2024
2:05 PM - 2:15 PM
General Session

Case Discussions

Friday, November 01, 2024
2:15 PM - 2:55 PM